SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-020080
Filing Date
2020-09-23
Accepted
2020-09-23 13:15:04
Documents
26
Period of Report
2020-09-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20200922_8k.htm 8-K 35624
2 EXHIBIT 99.1 ex_204746.htm EX-99.1 14685
3 slide01.jpg GRAPHIC 33590
4 slide02.jpg GRAPHIC 119951
5 slide03.jpg GRAPHIC 53987
6 slide04.jpg GRAPHIC 60117
7 slide05.jpg GRAPHIC 56159
8 slide06.jpg GRAPHIC 62807
9 slide07.jpg GRAPHIC 64831
10 slide08.jpg GRAPHIC 62830
11 slide09.jpg GRAPHIC 49399
12 slide10.jpg GRAPHIC 57057
13 slide11.jpg GRAPHIC 42840
14 slide12.jpg GRAPHIC 49136
15 slide13.jpg GRAPHIC 36732
16 slide14.jpg GRAPHIC 39452
17 slide15.jpg GRAPHIC 37874
18 slide16.jpg GRAPHIC 43664
19 slide17.jpg GRAPHIC 56123
20 slide18.jpg GRAPHIC 49482
21 slide19.jpg GRAPHIC 64281
22 slide20.jpg GRAPHIC 51886
23 slide21.jpg GRAPHIC 57177
24 slide22.jpg GRAPHIC 48091
25 slide23.jpg GRAPHIC 54318
26 slide24.jpg GRAPHIC 18571
  Complete submission text file 0001437749-20-020080.txt   1799405
Mailing Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080
Business Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 201191560
SIC: 2836 Biological Products, (No Diagnostic Substances)